dengue
ReadyGo Diagnostics, Gemina Labs Expand Infectious Disease MDx Development Pact With Dengue Test
Premium
The partnership is an example of UK-based ReadyGo's strategy to develop molecular infectious disease assays with partners internationally.
Climate Change Poses New Challenges for Dx Industry With Potential Emergence of New Diseases
Premium
While many firms have yet to take practical steps dealing with the potential disease implications of climate change, they may soon find they'll have to.
BioMérieux Gets CE Mark for Three Dengue Immunoassays
The three tests run on the firm's Vidas systems and expand the firm's footprint in vector-borne disease.
Startup CRISPR Firm Caspr Biotech Developing COVID Dx Using New Extremophile Bacteria Nuclease
Caspr's assay can be transported at room temperature and performed without complex external equipment, making it ideal for low-resource environments.
Kephera Diagnostics Wins $2M SBIR Grant From NIAID to Develop Zika Virus Antibody Test
The test is aimed at detecting Zika antibodies in a highly specific way that avoids cross-reactivity with the dengue virus, according to the firm.
Dec 9, 2019
Aug 6, 2019
Chembio Diagnostics Q2 Revenues Rise 10 Percent
Mar 20, 2019
Sep 12, 2018
FDA Clears InBios Dengue Detection Assay
Sep 27, 2017